Navigation Links
China Cord Blood Corporation Announces Partial Exercise of Over-Allotment Option
Date:12/31/2009

of a variety of factors, including the risks associated with the effect of changing economic conditions in the People's Republic of China, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.


    For more information, please contact:
    China Cord Blood Corporation
    Ms. Joeling Law
    Phone: +852-3605-8180
    Email: ir@chinacordbloodcorp.com

    ICR, Inc.
    In the United States:
    Ashley M. Ammon or Christine Duan
    Phone: +1-646-277-1227
    In China:
    Wei-Jung Yang
    Phone: +86-10-6599-7968

SOURCE China Cord Blood Corporation

RELATED LINKS
http://www.chinacordbloodcorp.com

'/>"/>

SOURCE China Cord Blood Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sinovacs CEO Weidong Yin Presented with Annual Innovation Award by China Central Television
2. American Oriental Bioengineering Announces the Inclusion of 158 Drugs in Chinas National Insurance Catalog
3. China Sky Medical, Inc. Has 30 Medicines that will Be Included in Chinas National Insurance Directory
4. China Biologic Products to Ring NASDAQ Opening Bell
5. Simcere Announces 105 Drugs Included in Chinas National Drug Reimbursement List
6. Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit
7. Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies
8. China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia
9. China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List
10. WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year
11. China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 Mathematic studies at the ... , and funded by the Jeffrey Epstein VI Foundation ... can be visually identified for elimination. These aggressive cells are ... which shows a topological map of what to look for ... research, for while tumor cells can be extracted from biopsy, ...
(Date:8/21/2014)... Calif. , Aug. 21, 2014  Four-dimensional ... and behaviors based on external stimuli such as ... to have a disruptive effect in multiple industries.  ... the business landscape by printing objects ranging from ... and automotive sectors. Logo - ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 ... biopharmaceutical contract development and manufacturing organization (CMO) announced ... Pharmaceuticals, Inc., an oncology company focused on the ... cancer, to manufacture the anti-prostate specific membrane antigen ... product candidate. Under the agreement the antibody ...
(Date:8/20/2014)... 2014 Clintrax Global, Inc., a worldwide ... Raleigh, NC , recently announced the ... President of Administration. As Vice ... processes, including their alignment with company objectives and ... as an HR executive, specializing in needs assessments, ...
Breaking Biology Technology:Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 3Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 4Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3Clintrax Global, Inc. Announces Addition to Executive Team 2
... MISSISSAUGA, ON, Oct. 22 /PRNewswire-FirstCall/ - YM BioSciences ... an oncology company that identifies,develops and commercializes differentiated ... of Directors has adopted a renewed,Shareholder Rights Plan ... fair treatment of shareholders in connection with any ...
... Call and Webcast to Follow, THE WOODLANDS, Texas, ... will release its third quarter 2007,financial results on Tuesday, ... will hold a conference call to discuss the,company,s results ... at 5:00 p.m. Eastern Time on October 30, 2007. ...
... Orchid Cellmark Inc.,(Nasdaq: ORCH ), a ... announced that it has signed a definitive purchase,agreement ... Inc.,for a purchase price of $5.6 million in ... Cellmark restricted common stock. The purchase price is,subject ...
Cached Biology Technology:YM Biosciences announces adoption of renewed Shareholders' Rights Plan 2YM Biosciences announces adoption of renewed Shareholders' Rights Plan 3Lexicon to Report Third Quarter 2007 Financial Results on October 30, 2007 2Orchid Cellmark to Purchase ReliaGene Technologies, Inc. 2Orchid Cellmark to Purchase ReliaGene Technologies, Inc. 3
(Date:8/21/2014)... study aimed at improving the food intake, health and ... homes is among three projects at the University of ... the Canadian Institutes of Health Research (CIHR). , ... Sciences at Waterloo, and a Schlegel research chair in ... to investigate why many Canadians living in long-term care ...
(Date:8/21/2014)... to Wednesday, Oct. 18-22, 2014 , WHERE: ... Drive, San Diego, CA 92101 , WHAT: ... presentations of the latest research in human genetics. ... featuring high-scoring abstracts on rare genetic variants in ... and treatment for sun sensitivity (Saturday, Oct. 18, ...
(Date:8/21/2014)... Researchers from North Carolina State University have developed a ... The model has applications for creating new materials as ... , "Our new technique allows us to model much ... so much more quickly," says Nan Li, lead author ... student in NC State,s Department of Materials Science and ...
Breaking Biology News(10 mins):Grants will fund landmark aging research at Waterloo 2American Society of Human Genetics 2014 Annual Meeting 2Researchers develop models to study polyelectrolytes, including DNA and RNA 2
... moss on a tree trunk always points north. According to ... may also provide a new "compass" for stem cell research, ... purposes. Dr. Nir Ohad of Tel Aviv ... the University of Freiburg have discovered a new use for ...
... a lot from an animal. By manipulating the DNA of ... deal about the genes and molecules behind many of life,s ... in people as they do in "model" animals. But if ... humans, ability to learn language from one another, you need ...
... of the research was to gather information on the effects ... and dynamic characteristics of plankton in the estuaries. The ... work entitled Impact of climate variability on the pelagic ecosystem ... Biscay): a time series analysis. He has studied the estuaries ...
Cached Biology News:Telltale moss 2Transgenic songbirds provide new tool to understand the brain 2University of Basque Country research study on effects of climate on plankton in the estuaries 2
... The European Collection of Cell Cultures (ECACC) ... West of the West of England, Bristol, ... the quality control of HER2, oestrogen and ... paraffin wax sections of formalin fixed, breast ...
... 3C protease from human rhinovirus (HRV 3C) ... brand line of restriction grade proteases. The ... 6XHis-fusion protein, which recognizes the same cleavage ... small, 22 KDa size of the protease, ...
...
... Continuing a tradition of progressive centrifuge design ... series. The Centra-CL3 and Centra-CL3R (refrigerated) general ... laboratory., Quality Control Over Sample Preparation ... lock up to 99 protocols and has ...
Biology Products: